作者:
Hongling,He [1]
;
Yating,Huang [1]
;
Xiubing,Zhang [2]
;
Yanting,Ouyang [3]
;
Piaopiao,Pan [4]
;
Yanling,Lan [1]
;
Zicheng,Zhong [1]
;
Lu,Ping [2]
;
Tiejun,Lu [5]
;
Zhenqiu,Chen [6]
;
Lei,Xing [7]
;
Qingguo,Li [8]
;
Zhenwen,Qiu [9]
作者单位:
School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou 510006, PR China.
[1]
The First Affiliated Hospital, Guangzhou University of Chinese Medicine, Guangzhou 510405, PR China.
[2]
Shunde Hospital of Guangzhou University of Chinese Medicine, Foshan 528329, Guangdong, PR China.
[3]
Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow G12 8QQ, UK.
[4]
Centre for Formulation Engineering, School of Chemical Engineering, University of Birmingham, Birmingham B15 2TT, UK.
[5]
The First Affiliated Hospital, Guangzhou University of Chinese Medicine, Guangzhou 510405, PR China. Electronic address: chenzhenqiu2012@126.com.
[6]
Department of Chemical and Process Engineering, University of Surrey, Guildford GU2 7XH, UK. Electronic address: l.xing@surrey.ac.uk.
[7]
School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou 510006, PR China. Electronic address: lqg8512@gzucm.edu.cn.
[8]
The First Affiliated Hospital, Guangzhou University of Chinese Medicine, Guangzhou 510405, PR China. Electronic address: qzhenwen@gzucm.edu.cn.
[9]
DOI
10.1016/j.ijpharm.2023.122593
PMID
36626970
发布时间
2023-03-13